Kant, Agnes https://orcid.org/0000-0003-3767-110X
van Hunsel, Florence https://orcid.org/0000-0001-8965-3224
Funding for this research was provided by:
Ministerie van Volksgezondheid, Welzijn en Sport (331.880)
Article History
Accepted: 20 June 2022
First Online: 15 July 2022
Declarations
:
: Funding for the cohort event monitoring of COVID-19 vaccine safety was granted by the Dutch Ministry of Health, Welfare and Sport (Grant 331.880). The Dutch Ministry of Health, Welfare and Sport had no role in the study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.
: The authors AK and FH declare no relevant conflicts of interest.
: If a study in the Netherlands is subject to the Medical Research Involving Human Subjects Act (WMO), it must undergo a review by an accredited Medical Research Ethics Committee or the central committee on research involving human subjects (CCMO). After submission to an accredited review committee (METC Brabant), this study was deemed not to fall under the WMO act.
: Participants in the study provided a written statement of consent to participate at the time of registration.
: Participants in the study provided a written statement of consent at the time of registration for their data to be used for the purpose of this research and publication of study results.
: The datasets for this manuscript are not publicly available because of the Lareb data protection policy. Requests to access the datasets should be directed to the first author and will be granted upon reasonable request.
: The SQL statements for the data used in this article are not publicly available because of the Lareb data protection policy. Requests to access the datasets should be directed to the first author and will be granted upon reasonable request.
: This response letter was drafted by both AKT and FHL and both approved the final version.
Free to read: This content has been made available to all.